Ulcerative Colitis

Ulcerative Colitis (UC) is a chronic, idiopathic inflammatory bowel disease characterized by diffuse, continuous mucosal inflammation limited to the colon and rectum. It typically presents with a relapsing-remitting course of bloody diarrhea, rectal urgency, and tenesmus.

The exact cause is unknown, but it arises from a dysregulated mucosal immune response to commensal gut microbiota in genetically susceptible individuals. Environmental triggers include NSAID use and smoking cessation (nicotine is paradoxically protective).

Inflammation begins in the rectum (proctitis) and extends continuously and symmetrically proximally. It is confined to the mucosa and submucosa (unlike the transmural involvement of Crohn's disease). Histologically, it features crypt architectural distortion, cryptitis, crypt abscesses, and goblet cell depletion.

• Prevalence: Highest in North America and Northern Europe (up to 250 per 100,000 individuals).
• Age: Bimodal distribution peaking at 15–30 years and 50–70 years.
• Gender: Equal male-to-female distribution.

• First-degree relative with IBD (strongest risk factor)
• Ashkenazi Jewish ancestry
• Age under 30 or over 50
• Former smoking status (cessation triggers flares)
• Frequent NSAID use

• Vitals: Normal in mild disease; tachycardia, hypotension, and hyperthermia in severe flares.
• Inspection: Mucosal pallor (anemia); signs of dehydration; extraintestinal skin lesions (erythema nodosum, pyoderma gangrenosum).
• Palpation: Left-sided or generalized abdominal tenderness without guarding; rebound tenderness suggests perforation.
• Auscultation: Hyperactive bowel sounds during flares; absent bowel sounds in toxic megacolon.

• A. Clinical Assessment: History of chronic diarrhea (>4 weeks) with blood.
• B. Laboratory Testing: Assessment of anemia, inflammatory markers, and exclusion of infectious etiologies.
• C. Imaging Studies: X-ray or CT of the abdomen to assess for bowel dilation/complications.
• D. Functional Tests: Fecal calprotectin to evaluate mucosal inflammation.
• E. Biopsy Findings: Endoscopic biopsy showing chronic inflammatory infiltrate, crypt abscesses, and architectural distortion.
• F. Genetic Testing: Not routinely recommended for clinical diagnosis.
• G. Differential Diagnosis: Infectious colitis, Crohn's disease, ischemic colitis, radiation proctitis.

Fecal Calprotectin
Type: Stool Test
Purpose: Differentiate IBD from irritable bowel syndrome (IBS) and monitor mucosal inflammation.
Expected Findings: Elevated levels (>50–100 μg/g).
Interpretation: Correlates directly with endoscopic disease activity. Complete Blood Count (CBC)
Type: Blood Test
Purpose: Screen for anemia and systemic inflammation.
Expected Findings: Microcytic anemia (low hemoglobin/MCV), leukocytosis, and thrombocytosis.
Interpretation: Severe anemia and high white count indicate moderate-to-severe disease activity.

Colonoscopy with Biopsy: Purpose: Gold standard for diagnosis and determining extent. Typical Findings: Continuous, mucosal erythema, loss of vascular pattern, friability, and pseudopolyps. Clinical Importance:* Confirms diagnosis and rules out malignancy.
Abdominal Plain Radiograph (X-ray): Purpose: Evaluate acute, severe flares. Typical Findings: Colonic dilation (>6 cm) in toxic megacolon or free air if perforated. Clinical Importance:* Critical tool in emergency screening.

• Crohn's Disease: Differentiated by transmural, patchy (skip) lesions, granulomas, and terminal ileum involvement.

• Ischemic Colitis: Typically older patients, sudden onset of pain, segmental distribution sparing the rectum.

• Toxic Megacolon
• Bowel Perforation
• Colorectal Cancer (risk increases with disease duration and extent)
• Primary Sclerosing Cholangitis (PSC)

Most patients experience a relapsing-remitting course. Approximately 10–15% will require surgical colectomy within 10 years of diagnosis. Life expectancy is generally comparable to the general population with appropriate medical maintenance.

There is no primary prevention. Secondary prevention relies on compliance with maintenance therapy and routine screening colonoscopies.

The following homeopathic remedies have been historically indicated for symptoms associated with Ulcerative Colitis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Ulcerative Colitis.